KYMERA THERAPEUTICS, INC.: accounts_payable
| Value | {"amount": 6494000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2024-09-30) |
| Status | current |
| Entity | KYMERA THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:15:33.181497+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/0e2caac8-0fd4-4ffe-9747-c628d3afad4c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-24-119249 · Open the official SEC filing →Retrieved: 2026-08-19T18:15:33.181497+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001815442/accounts-payable/2024-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/0e2caac8-0fd4-4ffe-9747-c628d3afad4c
History
- no predecessors — first report